Suppr超能文献

与成釉细胞瘤复发相关的因素:范围综述。

Factors Associated with Recurrence of Ameloblastoma: A Scoping Review.

机构信息

Section of Oral and Maxillofacial Pathology, Department of Oral Diagnostic Sciences, Faculty of Dentistry, Prince of Songkla University, Hatyai, Songkhla, Thailand.

Section of Oral and Maxillofacial Radiology, Department of Oral Diagnostic Sciences, Faculty of Dentistry, Prince of Songkla University, Hatyai, Songkhla, Thailand.

出版信息

Head Neck Pathol. 2024 Aug 23;18(1):82. doi: 10.1007/s12105-024-01686-7.

Abstract

PURPOSE

This scoping review aimed to identify factors associated with the recurrence of ameloblastoma.

METHODS

Systematic searches were conducted in PubMed, Scopus, and EMBASE, based on the board research question: "What factors are related to the recurrence of ameloblastoma?". English-language observational studies addressing the risk and preventive factors associated with recurrent ameloblastoma were included and data were extracted.

RESULTS

Eighty-three retrospective observational studies met the inclusion criteria. The identified prognostic factors for recurrence included: (1) Tumor size/diameter/volume, (2) cortical bone perforation/ soft tissue invasion, (3) multilocular radiolucency, (4) impacted tooth-involving lesions, (5) root resorption, (6) WHO classification - conventional (solid/multicystic) ameloblastoma, (7) histological subtype - mural invasion of unicystic ameloblastoma, (8) conservative treatment modalities - simple enucleation, curettage, and marsupialization, and (9) non-extraction/preservation of involved teeth. No strong evidence linked immunohistochemical expression to recurrence. Interestingly, BRAF p.V600E remained controversial in terms of recurrence, despite being a frequent finding in ameloblastoma.

CONCLUSION

Certain clinical characteristics, radiographic findings, histological subtypes, and treatment choices of ameloblastoma can help identify patients at high risk of recurrence. Further prospective studies to evaluate the prognostic factor model and research on immunohistochemistry are required.

摘要

目的

本范围综述旨在确定与成釉细胞瘤复发相关的因素。

方法

根据委员会提出的研究问题,在 PubMed、Scopus 和 EMBASE 中进行系统检索:“哪些因素与成釉细胞瘤的复发有关?”。纳入了涉及与复发性成釉细胞瘤相关的风险和预防因素的英文观察性研究,并提取了数据。

结果

83 项回顾性观察性研究符合纳入标准。确定的复发预测因素包括:(1)肿瘤大小/直径/体积,(2) 皮质骨穿孔/软组织侵犯,(3)多房性透亮区,(4)累及牙齿的埋伏性病变,(5)牙根吸收,(6)WHO 分类-常规(实性/多囊性)成釉细胞瘤,(7)组织学亚型-单囊型成釉细胞瘤的壁内侵犯,(8)保守治疗方法-单纯剜除、刮除和袋形术,以及(9)未拔牙/保留受累牙齿。没有强有力的证据表明免疫组织化学表达与复发有关。有趣的是,尽管 BRAF p.V600E 在成釉细胞瘤中频繁发现,但它与复发的相关性仍存在争议。

结论

成釉细胞瘤的某些临床特征、影像学表现、组织学亚型和治疗选择有助于识别复发风险较高的患者。需要进一步开展前瞻性研究来评估预后因素模型,并研究免疫组织化学。

相似文献

1
Factors Associated with Recurrence of Ameloblastoma: A Scoping Review.
Head Neck Pathol. 2024 Aug 23;18(1):82. doi: 10.1007/s12105-024-01686-7.
2
Clinicopathologic Profile and Surgical Modalities in Mandibular Ameloblastoma: A Descriptive Study.
J Craniofac Surg. 2024;35(1):158-162. doi: 10.1097/SCS.0000000000009706. Epub 2023 Sep 8.
3
Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis.
Int J Oral Maxillofac Surg. 2016 Mar;45(3):359-67. doi: 10.1016/j.ijom.2015.12.016. Epub 2016 Jan 11.
5
Unicystic ameloblastoma in children: systematic review of clinicopathological features and treatment outcomes.
Int J Oral Maxillofac Surg. 2014 Apr;43(4):405-12. doi: 10.1016/j.ijom.2014.01.003. Epub 2014 Feb 3.
6
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence.
Head Neck Pathol. 2025 Feb 17;19(1):22. doi: 10.1007/s12105-024-01743-1.
8
Clinicopathological characteristics of desmoplastic ameloblastoma: A systematic review.
J Investig Clin Dent. 2018 Feb;9(1). doi: 10.1111/jicd.12282. Epub 2017 Jul 14.
9
Prognosis of adults and children following a first unprovoked seizure.
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.

引用本文的文献

1
A scientometric study on research trends and characteristics of ameloblastoma.
J Dent Sci. 2025 Apr;20(2):1262-1266. doi: 10.1016/j.jds.2024.11.030. Epub 2024 Dec 11.

本文引用的文献

1
Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis.
J Oral Pathol Med. 2023 Sep;52(8):701-709. doi: 10.1111/jop.13458. Epub 2023 Jun 26.
2
Unicystic ameloblastoma: A retrospective study on recurrent factors from a single institute database.
Oral Dis. 2024 Apr;30(3):1475-1482. doi: 10.1111/odi.14477. Epub 2023 Jan 4.
3
Does Preservation of the Inferior Alveolar Nerve in the Close Margin of the Mandibular Ameloblastoma Increase the Risk of Recurrence?
J Oral Maxillofac Surg. 2023 Jan;81(1):101-106. doi: 10.1016/j.joms.2022.09.009. Epub 2022 Sep 22.
4
Effectiveness of Resective Surgery in of the Jaws: A Retrospective Multicenter Observational Study.
Cancers (Basel). 2022 Sep 22;14(19):4608. doi: 10.3390/cancers14194608.
5
FOSL1 promotes tumor growth and invasion in ameloblastoma.
Front Oncol. 2022 Sep 15;12:900108. doi: 10.3389/fonc.2022.900108. eCollection 2022.
6
Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience.
J Maxillofac Oral Surg. 2022 Jun;21(2):730-738. doi: 10.1007/s12663-022-01694-6. Epub 2022 Mar 17.
7
Histopathologic Feature of Hyalinization Predicts Recurrence of Conventional/Solid Multicystic Ameloblastomas.
Diagnostics (Basel). 2022 Apr 29;12(5):1114. doi: 10.3390/diagnostics12051114.
10
Fibular Free Flap and Iliac Crest Free Flap Mandibular Reconstruction In Patients With Mandibular Ameloblastomas.
J Craniofac Surg. 2022 Oct 1;33(7):1962-1970. doi: 10.1097/SCS.0000000000008524. Epub 2022 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验